Biogen Inc. (BIIB)
Drug Manufacturers - General · Healthcare · $28.9B
Intrinsic Value (Consensus)
$163.47
Current Price
$196.61
Margin of Safety
-16.9%
16.9% Above Intrinsic Value
Value: $163
Price: $197
Valuation Model Estimates
Current Price: $196.61
DCF (Discounted Cash Flow)
$194.48
Graham Number
$145.39
Earnings Power Value
$127.65
Relative Value (P/E)
$186.37
Dividend Discount Model
Not applicable
—
Consensus Value
$163.47
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
54
Profitability
15/25
Strength
23/25
Valuation
9/25
Growth
7/25
Key Financials
- EPS (TTM)
- $9.32
- EPS (Forward)
- $9.78
- Book Value
- $100.81
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 8.7%
- Debt/Equity
- 42%
- Revenue Growth
- 2.2%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 0.18
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance